文献速递系统性红斑狼疮其他结缔组织病

Egr2与Egr3在系统性自身免疫调控中的新兴作用

Emerging roles of Egr2 and Egr3 in the control of systemic autoimmunity.
PubMed 文献 · Rheumatology (Oxford) · 2016-01-01

本文综述早期生长反应基因2(Egr2)与Egr3在调控系统性自身免疫中的作用。缺失Egr2和Egr3的小鼠出现狼疮样疾病,伴效应T细胞活化失调;Egr2和Egr3赋予CD4+ T细胞抑制活性并调控IL-10、TGF-β1等抑制性细胞因子产生。作者认为其可能为免疫相关疾病治疗提供新思路。

要点

  • Egr2和Egr3缺失小鼠发生狼疮样疾病,伴效应T细胞活化失调
  • Egr2和Egr3赋予CD4+ T细胞抑制活性
  • Egr2和Egr3调控IL-10与TGF-β1等抑制性细胞因子产生

核心结论

  • Egr2和Egr3是抑制过度免疫反应的调控分子,其缺失可致狼疮样自身免疫,提示其可能成为治疗靶点。

研究设计与样本

  • 本文为综述,汇总利用基因工程小鼠及全基因组关联研究鉴定狼疮相关基因、以及Egr2和Egr3调控T细胞与自身免疫的最新进展。

主要发现

  • Egr2和Egr3缺陷小鼠发生狼疮样疾病,表现为效应T细胞活化失调。
  • Egr2和Egr3赋予CD4+ T细胞抑制活性。
  • Egr2和Egr3调控IL-10和TGF-β1等抑制性细胞因子的产生。

临床怎么用

  • 综述提出可利用Egr2和Egr3开发治疗应用的可能性,但未给出具体临床推荐或阈值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

SLE is an autoimmune disease characterized by multiple organ damage mediated by autoantibodies and autoreactive T cells. Approaches utilizing genetically engineered mice as well as genome-wide association studies have identified a number of lupus-related genes. Recently, early growth response gene 2 (Egr2) and Egr3 have emerged as regulatory molecules that suppress excessive immune responses. Mice deficient for Egr2 and Egr3 develop a lupus-like disease with dysregulated activation of effector T cells. Furthermore, Egr2 and Egr3 confer suppressive activity to CD4+ T cells and regulate the production of inhibitory cytokines such as IL-10 and TGF-β1. These findings may have implications for a wide range of immune-related pathologies and suggest the possibility that efforts exploiting Egr2 and Egr3 could aid in the development of therapeutic applications. This review summarizes the recent advances regarding the roles of Egr2 and Egr3 on T cells in the control of autoimmunity.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Morita K, Okamura T, Sumitomo S, et al. Emerging roles of Egr2 and Egr3 in the control of systemic autoimmunity. Rheumatology (Oxford). 2016. PMID: 27856665

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。